Companies covered: Medtronic, Inc. (NYSE:MDT), Baxter International Inc. (NYSE:BAX), Abbott Laboratories (NYSE:ABT), Tactile Systems Technology, Inc. (NASDAQ:TCMD), DexCom, Inc. (NASDAQ:DXCM), Inogen, Inc (NASDAQ:INGN), Edwards Lifesciences Corporation (NYSE:EW), ABIOMED, Inc. (NASDAQ:ABMD), Intuitive Surgical, Inc. (NASDAQ:ISRG), Amazon.com, Inc. (NASDAQ:AMZN), VolitionRX Limited (NYSEAMERICAN:VNRX), CryoPort Inc. (NASDAQ:CYRX), Gilead Sciences, Inc. (NASDAQ:GILD), Novartis AG (NYSE:NVS), Bristol-Myers Squibb Company (NYSE:BMY), Pfizer, Inc. (NYSE:PFE), Dare Bioscience (NASDAQ:DARE), Merck & Company, Inc. (NYSE:MRK), Biomerica Inc. (NASDAQ:BMRA), Allergan, Inc. (NYSE:AGN), Hologic, Inc. (NASDAQ:HOLX), International Business Machines Corporation (NYSE:IBM), Restoration Robotics, Inc. (NASDAQ:HAIR), Cure Pharmaceutical Holding Corp. (OTCMKTS:CURR), Motus GI Holdings, Inc. (NASDAQ:MOTS), Co-Diagnostics, Inc. (NASDAQ:CODX), electroCore, Inc. (NASDAQ:ECOR), ReWalk Robotics Ltd (NASDAQ:RWLK), CryoLife, Inc. (NYSE:CRY), Cardiovascular Systems, Inc. (NASDAQ:CSII), SurModics, Inc. (NASDAQ:SRDX), Johnson & Johnson (NYSE:JNJ), Insulet Corporation (NASDAQ:PODD), BioTelemetry, Inc. (NASDAQ:BEAT), UnitedHealth Group Incorporated (NYSE:UNH), CVS Health Corporation (NYSE:CVS), Aetna Inc. (NYSE:AET), Cigna Corporation (NYSE:CI), Express Scripts Holding Company (NASDAQ:ESRX)
